Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation products

Detalhes bibliográficos
Autor(a) principal: Tolić, Ljiljana
Data de Publicação: 2018
Outros Autores: Grujić, Svetlana, Laušević, Mila
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/153801
Resumo: Multifunctional drug anisomycin was subjected to forced degradation in accordance with International Conference on Harmonisation (ICH) guidelines for the first time. The drug was exposed to the recommended stress conditions of hydrolysis (acidic, alkaline and neutral), oxidation, thermal stress and photolysis, in order to investigate its stability. Optimized LC–MS/MS method was validated as recommended by ICH Q2(R1) guideline with respect to the specificity, accuracy, precision, limits of detection and quantitation, linearity and robustness. Anisomycin exhibited high instability under alkaline and thermal (neutral hydrolysis) conditions. It showed moderate stability under acidic, neutral, oxidative, thermal (acidic hydrolysis) and photolytic conditions, with the lowest degradation level observed in the case of light and oxidation stress. Formation of the same degradation product, identified as deacetylanisomycin, was observed under all applied stress conditions.
id USP-31_41e30bcc2fe86469d35ac246a3ccc722
oai_identifier_str oai:revistas.usp.br:article/153801
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation productsAnisomycin/forced degradationStability-indicatingLC–MS/MS/validationDeacetylanisomycinMultifunctional drug anisomycin was subjected to forced degradation in accordance with International Conference on Harmonisation (ICH) guidelines for the first time. The drug was exposed to the recommended stress conditions of hydrolysis (acidic, alkaline and neutral), oxidation, thermal stress and photolysis, in order to investigate its stability. Optimized LC–MS/MS method was validated as recommended by ICH Q2(R1) guideline with respect to the specificity, accuracy, precision, limits of detection and quantitation, linearity and robustness. Anisomycin exhibited high instability under alkaline and thermal (neutral hydrolysis) conditions. It showed moderate stability under acidic, neutral, oxidative, thermal (acidic hydrolysis) and photolytic conditions, with the lowest degradation level observed in the case of light and oxidation stress. Formation of the same degradation product, identified as deacetylanisomycin, was observed under all applied stress conditions.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2018-07-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/15380110.1590/s2175-97902018000217491Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 2 (2018); e17491Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 2 (2018); e17491Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 2 (2018); e174912175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/153801/150184Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessTolić, LjiljanaGrujić, SvetlanaLaušević, Mila2019-03-17T13:56:23Zoai:revistas.usp.br:article/153801Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-03-17T13:56:23Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation products
title Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation products
spellingShingle Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation products
Tolić, Ljiljana
Anisomycin/forced degradation
Stability-indicating
LC–MS/MS/validation
Deacetylanisomycin
title_short Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation products
title_full Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation products
title_fullStr Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation products
title_full_unstemmed Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation products
title_sort Development and validation of a stability-indicating LC–UV and LC–MS/MS methods for quantitative analysis of anisomycin and identification of degradation products
author Tolić, Ljiljana
author_facet Tolić, Ljiljana
Grujić, Svetlana
Laušević, Mila
author_role author
author2 Grujić, Svetlana
Laušević, Mila
author2_role author
author
dc.contributor.author.fl_str_mv Tolić, Ljiljana
Grujić, Svetlana
Laušević, Mila
dc.subject.por.fl_str_mv Anisomycin/forced degradation
Stability-indicating
LC–MS/MS/validation
Deacetylanisomycin
topic Anisomycin/forced degradation
Stability-indicating
LC–MS/MS/validation
Deacetylanisomycin
description Multifunctional drug anisomycin was subjected to forced degradation in accordance with International Conference on Harmonisation (ICH) guidelines for the first time. The drug was exposed to the recommended stress conditions of hydrolysis (acidic, alkaline and neutral), oxidation, thermal stress and photolysis, in order to investigate its stability. Optimized LC–MS/MS method was validated as recommended by ICH Q2(R1) guideline with respect to the specificity, accuracy, precision, limits of detection and quantitation, linearity and robustness. Anisomycin exhibited high instability under alkaline and thermal (neutral hydrolysis) conditions. It showed moderate stability under acidic, neutral, oxidative, thermal (acidic hydrolysis) and photolytic conditions, with the lowest degradation level observed in the case of light and oxidation stress. Formation of the same degradation product, identified as deacetylanisomycin, was observed under all applied stress conditions.
publishDate 2018
dc.date.none.fl_str_mv 2018-07-26
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/153801
10.1590/s2175-97902018000217491
url https://www.revistas.usp.br/bjps/article/view/153801
identifier_str_mv 10.1590/s2175-97902018000217491
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/153801/150184
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 2 (2018); e17491
Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 2 (2018); e17491
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 2 (2018); e17491
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222913732804608